Definitive Healthcare Corp. (NASDAQ:DH) Given Average Recommendation of “Hold” by Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been given an average recommendation of “Hold” by the eight research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, one has assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $2.7667.

A number of research analysts have recently commented on DH shares. Stephens cut their price target on Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a report on Friday, February 27th. Canaccord Genuity Group dropped their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating on the stock in a research report on Friday, February 27th. Wall Street Zen upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. Robert W. Baird set a $1.10 price target on shares of Definitive Healthcare in a report on Friday, May 8th. Finally, Barclays decreased their price target on shares of Definitive Healthcare from $2.75 to $1.00 and set an “underweight” rating on the stock in a research report on Monday, March 30th.

Definitive Healthcare Stock Up 2.1%

DH stock opened at $0.85 on Friday. The stock has a market capitalization of $89.59 million, a price-to-earnings ratio of -0.52, a price-to-earnings-growth ratio of 11.18 and a beta of 1.33. The company has a 50-day moving average of $0.95 and a two-hundred day moving average of $1.64. Definitive Healthcare has a 52-week low of $0.80 and a 52-week high of $4.70. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.75 and a quick ratio of 1.75.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03. Definitive Healthcare had a positive return on equity of 4.04% and a negative net margin of 76.04%.The business had revenue of $55.93 million during the quarter, compared to analysts’ expectations of $55.02 million. Definitive Healthcare has set its Q2 2026 guidance at 0.030-0.040 EPS and its FY 2026 guidance at 0.160-0.19 EPS. As a group, equities research analysts anticipate that Definitive Healthcare will post 0.05 EPS for the current year.

Hedge Funds Weigh In On Definitive Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in DH. Goldman Sachs Group Inc. raised its holdings in Definitive Healthcare by 564.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock valued at $25,191,000 after acquiring an additional 7,404,363 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Definitive Healthcare by 1.6% during the third quarter. Dimensional Fund Advisors LP now owns 2,073,197 shares of the company’s stock valued at $8,417,000 after purchasing an additional 33,612 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in shares of Definitive Healthcare by 11.7% in the third quarter. Arrowstreet Capital Limited Partnership now owns 1,216,007 shares of the company’s stock valued at $4,937,000 after purchasing an additional 127,055 shares in the last quarter. Bank of America Corp DE lifted its position in Definitive Healthcare by 23.7% in the second quarter. Bank of America Corp DE now owns 769,397 shares of the company’s stock worth $3,001,000 after purchasing an additional 147,599 shares during the period. Finally, Inspire Investing LLC lifted its position in Definitive Healthcare by 505.7% in the fourth quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock worth $2,006,000 after purchasing an additional 583,562 shares during the period. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.